Induction of antigen‐specific human CD4+ T cell anergy by peripheral blood DC2 precursors

Dendritic cells (DC) are antigen (Ag)‐presenting cells that are essential for initiation of T cell‐dependent immunity, and distinct DC subsets are known to direct different classes of immune responses. DC2 precursors (pDC2) or plasmacytoid DC were recently identified as a Th2‐skewing and IFN‐α‐producing human DC subset. Here, we demonstrate that pDC2 enriched from human peripheral blood have a capacity to induce an anergic state in human Ag‐specific CD4+ T cell lines. Tetanus toxoid‐specific T cell lines incubated with tetanus toxoid‐pulsed autologous pDC2 failed to proliferate in secondary cultures with optimal Ag stimulation. T cell anergy induction required TCR engagement with Ag/MHC complex presented on pDC2. T cells rendered anergic lost IL‐2 production but produced IFN‐γ and IL‐10 upon stimulation. The pDC2‐induced unresponsiveness was completely or partially reversible when a high concentration of exogenous IL‐2 was added in the secondary cultures. Autoreactive CD4+ T cell clones specific for topoisomerase I derived from a patient with scleroderma were also rendered anergic after co‐culture with topoisomerase I‐pulsed autologous pDC2,resulting in failure to proliferate or provide help to B cells. These results suggest that pDC2 are involved in maintenance of peripheral T cell tolerance and have potential for use in the suppression of pathogenic T cell responses in autoimmune diseases and organ transplantation.

[1]  Nina Bhardwaj,et al.  Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[2]  A. Enk,et al.  Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells , 2000, The Journal of experimental medicine.

[3]  A. Lanzavecchia,et al.  Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization , 2000, Nature Immunology.

[4]  J. Banchereau,et al.  Flt3-Ligand and Granulocyte Colony-Stimulating Factor Mobilize Distinct Human Dendritic Cell Subsets In Vivo1 , 2000, The Journal of Immunology.

[5]  T. Medsger,et al.  Analysis of Soluble and Cell Surface Factors Regulating Anti-DNA Topoisomerase I Autoantibody Production Demonstrates Synergy Between Th1 and Th2 Autoreactive T Cells1 , 2000, The Journal of Immunology.

[6]  A. García-Sastre,et al.  Type I IFN Modulates Innate and Specific Antiviral Immunity1 , 2000, The Journal of Immunology.

[7]  S. Heimfeld,et al.  Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. , 2000, Blood.

[8]  G. Schuler,et al.  Culture of bone marrow cells in GM‐CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen‐ specific CD4 T cell anergy in vitro , 2000, European journal of immunology.

[9]  H. Link,et al.  Dendritic cells in experimental allergic encephalomyelitis and multiple sclerosis , 1999, Journal of Neuroimmunology.

[10]  G. Stingl,et al.  Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. , 1999, Journal of immunology.

[11]  D. Davies,et al.  Human peripheral blood contains two distinct lineages of dendritic cells , 1999, European journal of immunology.

[12]  T. Ito,et al.  A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. , 1999, Journal of immunology.

[13]  Onji,et al.  Transfer of dendritic cells (DC) ex vivo stimulated with interferon‐gamma (IFN‐γ) down‐modulates autoimmune diabetes in non‐obese diabetic (NOD) mice , 1999, Clinical and experimental immunology.

[14]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[15]  D. Wraith,et al.  Mechanisms of central and peripehral T‐cell tolerance: lessons from experimental models of multiple sclerosis , 1999, Immunological reviews.

[16]  D. Avigan Dendritic cells: development, function and potential use for cancer immunotherapy. , 1999, Blood reviews.

[17]  N. Kadowaki,et al.  Reciprocal control of T helper cell and dendritic cell differentiation. , 1999, Science.

[18]  F. Sallusto,et al.  Mobilizing Dendritic Cells for Tolerance, Priming, and Chronic Inflammation , 1999, The Journal of experimental medicine.

[19]  Dirk Schadendorf,et al.  Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells , 1998, Nature Medicine.

[20]  A. Enk,et al.  Induction of tolerance by IL-10-treated dendritic cells. , 1997, Journal of immunology.

[21]  R. Steinman,et al.  Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors , 1997, The Journal of experimental medicine.

[22]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[23]  T. Medsger,et al.  Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope. , 1997, Journal of immunology.

[24]  R. Steinman,et al.  Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. , 1996, Journal of immunological methods.

[25]  Freddie H. Fu,et al.  Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. , 1996, Transplantation.

[26]  R. Schwartz,et al.  Models of T Cell Anergy: Is There a Common Molecular Mechanism? , 1996 .

[27]  T. Medsger,et al.  Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides. , 1995, Clinical immunology and immunopathology.

[28]  H. Weiner,et al.  Mechanisms of Acquired Thymic Tolerance in Experimental Autoimmtme Encephalomyelitis: Thymic Dendritic-enriched Cells Induce Specific Peripheral T Cell Unresponsiveness In Vivo By Samia J. Khoury,* Lorenzo Gallon, Wanjun Chen,* , 1995 .

[29]  Liangji Zhou,et al.  Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. , 1995, Journal of immunology.

[30]  J. Banchereau,et al.  Activation of human dendritic cells through CD40 cross-linking , 1994, The Journal of experimental medicine.

[31]  R. Steinman,et al.  Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. , 1994, Immunology.

[32]  R. Steinman,et al.  Proliferating dendritic cell progenitors in human blood , 1994, The Journal of experimental medicine.

[33]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[34]  R. Steinman,et al.  Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium , 1993, Journal of Experimental Medicine.

[35]  J. Gribben,et al.  Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Clare-Salzler,et al.  Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. , 1992, The Journal of clinical investigation.

[37]  V. Desmet,et al.  Plasmacytoid T cells: a cell population normally present in the reactive lymph node. An immunohistochemical and electronmicroscopic study. , 1988, Human pathology.

[38]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.